Cargando…

Subclinical AKI is still AKI

The concept of acute kidney syndromes has shifted in recent years from acute renal failure to acute kidney injury (AKI). AKI implies injury or damage but not necessarily dysfunction. The human kidney has an important glomerular function reserve, and dysfunction becomes evident only when more than 50...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronco, Claudio, Kellum, John A, Haase, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580601/
https://www.ncbi.nlm.nih.gov/pubmed/22721504
http://dx.doi.org/10.1186/cc11240
_version_ 1782260287357845504
author Ronco, Claudio
Kellum, John A
Haase, Michael
author_facet Ronco, Claudio
Kellum, John A
Haase, Michael
author_sort Ronco, Claudio
collection PubMed
description The concept of acute kidney syndromes has shifted in recent years from acute renal failure to acute kidney injury (AKI). AKI implies injury or damage but not necessarily dysfunction. The human kidney has an important glomerular function reserve, and dysfunction becomes evident only when more than 50% of the renal mass is compromised. Recent AKI classifications include even slight changes in serum creatinine, acknowledging that this condition is associated with worse outcomes. This, however, still represents a functional criterion for AKI and implies a glomerular filtration rate alteration that may be a late phenomenon in the time course of the syndrome. An early diagnosis of AKI by using tubular damage biomarkers preceding filtration function loss is possible today. Some studies have shown evidence that there is an additional value of new biomarkers not only because they allow a diagnosis to be made earlier but also because they allow a kidney injury to be diagnosed even in the absence of subsequent dysfunction. Only recently, tubular damage without glomerular function loss was demonstrated to be associated with worse renal and overall outcomes. For this condition, the term 'subclinical' AKI has been introduced, challenging the traditional view that a kidney problem is clinically relevant, only when a loss of filtration function becomes apparent. A new domain of AKI diagnosis could then include functional criteria and damage criteria. This may have an impact on the epidemiology, prevention, and management of AKI.
format Online
Article
Text
id pubmed-3580601
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35806012013-06-21 Subclinical AKI is still AKI Ronco, Claudio Kellum, John A Haase, Michael Crit Care Viewpoint The concept of acute kidney syndromes has shifted in recent years from acute renal failure to acute kidney injury (AKI). AKI implies injury or damage but not necessarily dysfunction. The human kidney has an important glomerular function reserve, and dysfunction becomes evident only when more than 50% of the renal mass is compromised. Recent AKI classifications include even slight changes in serum creatinine, acknowledging that this condition is associated with worse outcomes. This, however, still represents a functional criterion for AKI and implies a glomerular filtration rate alteration that may be a late phenomenon in the time course of the syndrome. An early diagnosis of AKI by using tubular damage biomarkers preceding filtration function loss is possible today. Some studies have shown evidence that there is an additional value of new biomarkers not only because they allow a diagnosis to be made earlier but also because they allow a kidney injury to be diagnosed even in the absence of subsequent dysfunction. Only recently, tubular damage without glomerular function loss was demonstrated to be associated with worse renal and overall outcomes. For this condition, the term 'subclinical' AKI has been introduced, challenging the traditional view that a kidney problem is clinically relevant, only when a loss of filtration function becomes apparent. A new domain of AKI diagnosis could then include functional criteria and damage criteria. This may have an impact on the epidemiology, prevention, and management of AKI. BioMed Central 2012 2012-06-21 /pmc/articles/PMC3580601/ /pubmed/22721504 http://dx.doi.org/10.1186/cc11240 Text en Copyright ©2012 BioMed Central Ltd
spellingShingle Viewpoint
Ronco, Claudio
Kellum, John A
Haase, Michael
Subclinical AKI is still AKI
title Subclinical AKI is still AKI
title_full Subclinical AKI is still AKI
title_fullStr Subclinical AKI is still AKI
title_full_unstemmed Subclinical AKI is still AKI
title_short Subclinical AKI is still AKI
title_sort subclinical aki is still aki
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580601/
https://www.ncbi.nlm.nih.gov/pubmed/22721504
http://dx.doi.org/10.1186/cc11240
work_keys_str_mv AT roncoclaudio subclinicalakiisstillaki
AT kellumjohna subclinicalakiisstillaki
AT haasemichael subclinicalakiisstillaki